FES and ovarian cancer: Increased FES expression colocalised with increased birth weight, increased ovarian cancer risk and decreased blood pressure along with decreased risk of hypertension and other related cardiovascular events and increased FURIN colocalised with decreased birth weight and increased angina risk (S5 Table).